PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DS23F00358509606737!carestart covid-19 antigen h — Access Bio, Inc

PoP ended May 11, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support
Awarding office
Department of Defense (DOD)
Agency
Access Bio, Inc
Recipient
May 11, 2023
PoP end
$205.2M
Obligated
325413
NAICS
6640
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Access Bio, Inc — $90

Contract facts

Federal
Contract numberSPE2DS23F0035
Also listed asSPE2DS-23-F-0035
Also listed asSPE2DE23D0011-SPE2DS23F0035
AgencyDepartment of Defense (DOD)
Awarding officeDla Troop Support
IncumbentAccess Bio, Inc
UEIEZEJBJ28AMV4
NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6640
Parent IDIQ / IDVSPE2DE23D0011
Place of performanceSOMERSET, NJ
PoP end (current)May 11, 2023
Obligated$205.2M

8509606737!CARESTART COVID-19 ANTIGEN H is a federal award for Department of Defense (DOD) held by Access Bio, Inc. Estimated value $205.2M ($205.2M obligated). Current period of performance ends May 11, 2023. Place of performance: SOMERSET, NJ.

Recompete timing

Public
Past PoP end (1218 days ago)

Current PoP ended May 11, 2023 (1218 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Explore more pipelines →

Frequently asked questions

What is contract SPE2DS23F0035?

SPE2DS23F0035 (8509606737!carestart covid-19 antigen h) is a Dla Troop Support award with an estimated value of $205.2M, currently held by Access Bio, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is SPE2DS-23-F-0035?

SPE2DS-23-F-0035 is the dashed form of PIID SPE2DS23F0035 (8509606737!carestart covid-19 antigen h), held by Access Bio, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded SPE2DS23F0035?

Dla Troop Support awarded SPE2DS23F0035 to Access Bio, Inc.

Who is the incumbent on SPE2DS23F0035?

Access Bio, Inc is the incumbent. The current period of performance ends May 11, 2023.

When does Access Bio, Inc’s SPE2DS23F0035 come up for recompete?

SCOUT tracks a period-of-performance end of May 11, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on SPE2DS23F0035 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2DS23F0035